(Q38464229)
English
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) stu
scientific article published on 10 September 2012
Statements
1 reference
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) stu (English)
1 reference
Jean Jacques Grob
1 reference
Genevieve Chene
1 reference
Axel Hauschild
1 reference
Thomas Jouary
1 reference
Julien Asselineau
1 reference
Ralf Gutzmer
1 reference
Marie Thérèse Leccia
1 reference
Michael Landthaler
1 reference
Claus Garbe
1 reference
Bruno Sassolas
1 reference
Rudolf A Herbst
1 reference
Bernard Guillot
1 reference
Hubert Pehamberger
1 reference
10 September 2012
1 reference
1 reference
49
1 reference
1
1 reference
166-174
1 reference
Identifiers
1 reference
1 reference